Keywords: apolipoprotein B; cholesterol; dyslipidaemias; high-density lipoproteins; lipoprotein remnants; low-density lipoproteins; total cardiovascular risk; treatment, adherence; treatment, drugs; treatment, lifestyle; triglycerides.